September 26, 2016 by Scot Meyer and Chain Drug Review
Alex Gourlay, EnvisionRx, EnvisionRxOptions, Frank Sheehy, Jocelyn Konrad, maintenance medications, Rite Aid, Rx90, Walgreens
2016, Issue 09-26-2016, Issues, News
DEERFIELD, Ill. — Walgreens and EnvisionRx are launching a prescription drug program that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications. Called Rx90, the program allows patients to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide for the same price they would pay for
September 12, 2016 by John Schultz and Chain Drug Review
EnvisionRx, Frank Sheehy, Jocelyn Konrad, Rite Aid, Rx90
2016, Issue 09-12-2016, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. and EnvisionRx, the pharmacy benefit management division of EnvisionRxOptions and a wholly owned subsidiary of Rite Aid, have debuted Rx90, a new program focused on improving medication adherence and health outcomes for consumers with chronic conditions. Rx90, now available for EnvisionRx clients, gives consumers the option to fill
August 17, 2016 by Chain Drug Review
EnvisionPharmacies, EnvisionRx, EnvisionRxOptions, Frank Sheehy, Jocelyn Konrad, John Standley, pharmacy benefit management, Rite Aid, Rx90
Featured Articles, Leading Headlines, Pharmacy, Retail News
CAMP HILL, Pa. — A new prescription drug program from Rite Aid Corp. and its EnvisionRx pharmacy benefit management arm gives patients with chronic conditions more flexibility in getting their maintenance medications. Called Rx90, the program enables patients to fill 90-day prescriptions at any of Rite Aid’s nearly 4,600 pharmacies or, for the same price,
September 28, 2015 by Chain Drug Review
Darren Karst, EnvisionRx, Frank Sheehy, Health Dialog, John Standley, RediClinic, Rite Aid, wellness+ with Plenti
2015, Issue 09-28-2015, Issues, News
CAMP HILL, Pa. — A new chapter opened for Rite Aid Corp. in its fiscal 2016 second quarter, as the company began reporting financial results under a new structure that incorporates recently acquired pharmacy benefit manager (PBM) EnvisionRx. Going forward, Rite Aid will report results in two business segments: retail pharmacy (including Rite Aid drug
August 3, 2015 by Chain Drug Review
David Abelman, EnvisionRx, Frank Sheehy, Health Dialog, Jocelyn Konrad, John Learish, John Standley, Ken Martindale, RediClinic, Rite Aid, Robert Thompson, Tony Montini, Web Golinkin, Wellness Stores, Wilson Lester
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — In a reorganization of key leadership, Rite Aid Corp. has promoted president and chief operating officer Ken Martindale to the newly created position of chief executive officer of Rite Aid stores. The drug chain said late Monday that Martindale, 55, takes the new post effective immediately and will continue to report
July 6, 2015 by Mark Baumgartner and Chain Drug Review
Envision Pharmaceutical Services, EnvisionRx, Frank Sheehy, John Standley, PBM, Rite Aid
2015, Issue 07-06-2015, Issues, News
CAMP HILL, Pa. — Rite Aid has completed its acquisition of Envision Pharmaceutical Services from private investment firm TPG and other shareholders in a transaction valued at about $2 billion, including about $1.8 billion in cash, and around 27.9 million Rite Aid shares. EnvisionRx will operate as a wholly owned subsidiary of Rite Aid under
June 24, 2015 by Chain Drug Review
Envision Pharmaceutical Services, EnvisionRx, Frank Sheehy, John Standley, PBM, pharmacy benefit management, Rite Aid
Business, Leading Headlines, Pharmacy, Retail News
CAMP HILL, Pa. — Rite Aid Corp. has finalized its acquisition of pharmacy benefit management company Envision Pharmaceutical Services. The closing of the deal, valued at about $2 billion, came early in the timetable that Rite Aid initially reported. When the acquisition was announced in February, Rite Aid said it expected to complete the transaction
March 16, 2015 by Greg Jacobson and Chain Drug Review
EnvisionRx, Frank Sheehy, John Standley, PBM, pharmacy benefits manager, Rite Aid
2015, Issue 03-16-2015, News
CAMP HILL, Pa. — Rite Aid Corp. has broadened and deepened its health care footprint by agreeing to acquire pharmacy benefits manager Envision Pharmaceutical Services (EnvisionRx) for around $2 billion in cash and stock from TPG, a private investment firm. The transaction, which has been approved by the boards of directors of both companies, is
February 11, 2015 by Chain Drug Review
EnvisionRx, Frank Sheehy, John Standley, Rite Aid
Retail News
CAMP HILL, Pa. — Rite Aid Corp. has taken another decisive step in its drive to expand its footprint in health care, agreeing to acquire Envision Pharmaceutical Services (EnvisionRx), a full-service pharmacy benefits management company, in a cash-and-stock deal valued at about $2 billion. Rite Aid said Wednesday that it expects the acquisition of EnvisionRx, now